Cargando…
Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
BACKGROUND: From May 2020 to January 2021, we enrolled 1233 health care workers (HCW) from Danish Hospitals in a randomized trial evaluating whether Bacille Calmette-Guérin (BCG) provides protection against COVID-19. Participants were randomized 1:1 to BCG vs saline and followed for 6 months. From D...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685493/ https://www.ncbi.nlm.nih.gov/pubmed/34930152 http://dx.doi.org/10.1186/s12879-021-06949-0 |
_version_ | 1784617843468271616 |
---|---|
author | Mohamed, Libin Madsen, Anne Marie Rosendahl Schaltz-Buchholzer, Frederik Ostenfeld, Anne Netea, Mihai G. Benn, Christine Stabell Kofoed, Poul-Erik |
author_facet | Mohamed, Libin Madsen, Anne Marie Rosendahl Schaltz-Buchholzer, Frederik Ostenfeld, Anne Netea, Mihai G. Benn, Christine Stabell Kofoed, Poul-Erik |
author_sort | Mohamed, Libin |
collection | PubMed |
description | BACKGROUND: From May 2020 to January 2021, we enrolled 1233 health care workers (HCW) from Danish Hospitals in a randomized trial evaluating whether Bacille Calmette-Guérin (BCG) provides protection against COVID-19. Participants were randomized 1:1 to BCG vs saline and followed for 6 months. From December 2020, Covid-19 vaccines were offered to the HCW. In most cases, BCG vaccination results in a characteristic scar. Reactivation of the BCG scar has been described in children during viral infections and following influenza vaccination, but is mostly associated to Kawasaki’s disease, a disease entity with pathogenesis likely similar to the child Covid-19 complication MIS-C: Multi-System Inflammatory Syndrome. Reactivation of scars after neonatal BCG vaccination has recently been described in four women after Covid-19 mRNA vaccination. Two of our trial participants experienced reactivation of their novel BCG scars after receiving mRNA Covid-19 vaccination 6 to 8 months post-BCG. CASE PRESENTATIONS: Two female HCW participants that had been randomly allocated to BCG in the BCG-DENMARK-COVID trial, spontaneously reported itching and secretion at the BCG scar site after having received mRNA Covid-19 vaccination (Moderna and Pfizer-BioNTech) 6 to 8 months following inclusion and BCG vaccination. One participant, who had a larger BCG skin reaction, noticed re-appearing symptoms after both the first and the second COVID-vaccine dose, while the other participant only noted symptoms after the second dose. Both had been BCG vaccinated during childhood, and no reactivation was noted in the older scars. No treatment was needed or provided. CONCLUSIONS: The reactivation of the BCG scar after receiving mRNA vaccine might have been caused by cross-reactivity between BCG and SARS-CoV-2. In both cases, the symptoms were bothersome, but self-limiting and left no sequelae. The risk of reactivation at the scar site is thus not a reason to avoid vaccination with either vaccine. |
format | Online Article Text |
id | pubmed-8685493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86854932021-12-20 Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports Mohamed, Libin Madsen, Anne Marie Rosendahl Schaltz-Buchholzer, Frederik Ostenfeld, Anne Netea, Mihai G. Benn, Christine Stabell Kofoed, Poul-Erik BMC Infect Dis Case Report BACKGROUND: From May 2020 to January 2021, we enrolled 1233 health care workers (HCW) from Danish Hospitals in a randomized trial evaluating whether Bacille Calmette-Guérin (BCG) provides protection against COVID-19. Participants were randomized 1:1 to BCG vs saline and followed for 6 months. From December 2020, Covid-19 vaccines were offered to the HCW. In most cases, BCG vaccination results in a characteristic scar. Reactivation of the BCG scar has been described in children during viral infections and following influenza vaccination, but is mostly associated to Kawasaki’s disease, a disease entity with pathogenesis likely similar to the child Covid-19 complication MIS-C: Multi-System Inflammatory Syndrome. Reactivation of scars after neonatal BCG vaccination has recently been described in four women after Covid-19 mRNA vaccination. Two of our trial participants experienced reactivation of their novel BCG scars after receiving mRNA Covid-19 vaccination 6 to 8 months post-BCG. CASE PRESENTATIONS: Two female HCW participants that had been randomly allocated to BCG in the BCG-DENMARK-COVID trial, spontaneously reported itching and secretion at the BCG scar site after having received mRNA Covid-19 vaccination (Moderna and Pfizer-BioNTech) 6 to 8 months following inclusion and BCG vaccination. One participant, who had a larger BCG skin reaction, noticed re-appearing symptoms after both the first and the second COVID-vaccine dose, while the other participant only noted symptoms after the second dose. Both had been BCG vaccinated during childhood, and no reactivation was noted in the older scars. No treatment was needed or provided. CONCLUSIONS: The reactivation of the BCG scar after receiving mRNA vaccine might have been caused by cross-reactivity between BCG and SARS-CoV-2. In both cases, the symptoms were bothersome, but self-limiting and left no sequelae. The risk of reactivation at the scar site is thus not a reason to avoid vaccination with either vaccine. BioMed Central 2021-12-20 /pmc/articles/PMC8685493/ /pubmed/34930152 http://dx.doi.org/10.1186/s12879-021-06949-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Mohamed, Libin Madsen, Anne Marie Rosendahl Schaltz-Buchholzer, Frederik Ostenfeld, Anne Netea, Mihai G. Benn, Christine Stabell Kofoed, Poul-Erik Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title_full | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title_fullStr | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title_full_unstemmed | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title_short | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports |
title_sort | reactivation of bcg vaccination scars after vaccination with mrna-covid-vaccines: two case reports |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685493/ https://www.ncbi.nlm.nih.gov/pubmed/34930152 http://dx.doi.org/10.1186/s12879-021-06949-0 |
work_keys_str_mv | AT mohamedlibin reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT madsenannemarierosendahl reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT schaltzbuchholzerfrederik reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT ostenfeldanne reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT neteamihaig reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT bennchristinestabell reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports AT kofoedpoulerik reactivationofbcgvaccinationscarsaftervaccinationwithmrnacovidvaccinestwocasereports |